The present invention is directed to compounds comprising a triazolo[4,3-b]pyridazine moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention ##STR1##

 
Web www.patentalert.com

< Peptidoglycan recognition proteins

< Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof

> 3-glyoxylamideindoles for treating cancer

> Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them
~ 00217